CRISPR/Cas-9 vector system: targets UL-39 and inhibits Simplexvirus humanalpha1 (HSV-1) replication in vitro
Cellular and Molecular Biology · 2023
DOI: 10.14715/cmb/2023.69.7.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular and Molecular Biology, 2023. Verfasst von Jéssica Vasques Raposo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Virology and Parasitology Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. jessicavasquesr@gmail.com. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Herpesvirus 1, Human. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Simplexvirus humanalpha1 (HSV-1) affects approximately 67% of the world's population. Here, we sought to use the CRISPR / Cas9 system with the UL39 target, essential for virus replication. The sgRNA sequence was inserted into the plasmid (PX459-UL39). Vero cells were transfected with PX459-UL39, and inhibition of viral replication was assessed 24 and 48 hours later using plaque assays and fluorescence and qPCR. Fluorescence analyses revealed the presence of anti-HSV-1 CRISPR/Cas9 within Vero cells, and qPCR showed that the viral load decreased by> 95% of cells transfected with anti-HSV-1 CRISPR / Cas 9. Our data demonstrate the usefulness of the PX459-UL39 to inhibit HSV-1 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Virology and Parasitology Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. jessicavasquesr@gmail.com.
- Program of Immunology and Tumor Biology. Division of Experimental and Translational Research. Brazilian National Cancer Institute - INCA. lucianalpt@gmail.com.
- Molecular Virology and Parasitology Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. lauana.rtorres@gmail.com.
- Molecular Virology and Parasitology Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. rafabarb26@edu.unirio.br.
- Molecular Virology and Parasitology Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. amanda.lopes.fiocruz@gmail.com.
- Molecular Virology and Parasitology Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. elenmellodesouza@gmail.com.
Zitieren
APA
Vasques Raposo, J., Rodrigues Carvalho Barros, L., Ribas Torres, L., Barbosa da Silva Pinto, R., De Oliveira Lopes, A., Mello de Souza, E., Hernan Bonamino, M., & Salete de Paula, V. (2023). CRISPR/Cas-9 vector system: targets UL-39 and inhibits Simplexvirus humanalpha1 (HSV-1) replication in vitro. Cellular and Molecular Biology. https://doi.org/10.14715/cmb/2023.69.7.3
Vancouver
Vasques Raposo J, Rodrigues Carvalho Barros L, Ribas Torres L, Barbosa da Silva Pinto R, De Oliveira Lopes A, Mello de Souza E, et al. CRISPR/Cas-9 vector system: targets UL-39 and inhibits Simplexvirus humanalpha1 (HSV-1) replication in vitro. Cellular and Molecular Biology. 2023. doi:10.14715/cmb/2023.69.7.3
BibTeX
@article{VasquesRaposo2023,
author = {Vasques Raposo, Jéssica and Rodrigues Carvalho Barros, Luciana and Ribas Torres, Lauana and Barbosa da Silva Pinto, Rafaela and De Oliveira Lopes, Amanda and Mello de Souza, Elen and Hernan Bonamino, Martin and Salete de Paula, Vanessa},
title = {CRISPR/Cas-9 vector system: targets UL-39 and inhibits Simplexvirus humanalpha1 (HSV-1) replication in vitro},
journal = {Cellular and Molecular Biology},
year = {2023},
doi = {10.14715/cmb/2023.69.7.3}
}
EUVIMED